Barbara Slusher explains the hit-to-lead optimization process, high-throughput screening, and the role of AI and organoids in modern drug discovery.
Business Wire: Elix Provides AI Drug Discovery Platform “Elix Discovery™” to Eisai
TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...
“It’s like a paradigm shift approach… to drive discovery”: a new machine-learning model predicts how molecules will influence gene expression and has been used to pick out promising drug candidates ...
News-Medical.Net: Why AI is becoming a powerful tool in cancer drug discovery
This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical translation, with an AI-designed TNIK inhibitor trial serving as an important ...
Researchers at McMaster University have developed a new generative artificial intelligence (AI) model capable of drastically speeding up drug discovery—and, in early tests, it has already designed a ...
EurekAlert!: Insilico Medicine integrates Nach01 Foundation Model with Microsoft Discovery to enable AI-native, enterprise-ready drug discovery workflows
Insilico Medicine integrates Nach01 Foundation Model with Microsoft Discovery to enable AI-native, enterprise-ready drug discovery workflows
MSN: New AI model could radically change genetic testing and drug discovery
Business Wire: Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
Nasdaq: Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment
Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment